6F: Navigating the Path of Biomaterials and Medical Products
Time: 1:30 PM to 3:30 PM
Description
The Biomaterials and Medical Products Commercialization SIG aims to provide researchers with the necessary tools to take their ideas from concept to physical product to market-ready technology. This session will focus on highlighting the various considerations needed on a product's journey to commercialization including, but not limited to, sterilization and purification, product scale-up and robust manufacturing, product purification, quality control, regulatory considerations, reimbursement strategies, supply chain, and market adoption. Examples will be provided from members of academia and industry, from small start-ups to large organizations, and from numerous markets and end-use applications. This session will hopefully inform and inspire the SFB community as they start and/or continue down the path of product development and commercialization.
Moderators:
Stephanie Steichen, The University of Texas at Austin
Brittany Givens Rassoolkhani, University of Kentucky
Scott Taylor, Poly-Med
Lauren Costella, Luna Labs
Brian Kwee, University of Delaware
Advanced Dry Gel Medical Device for Effective Prehospital Management of Junctional Hemorrhage
Development of the Secure Polymeric Tissue Tag (SPOTT) breast biopsy device
From Concept to Care: Successfully Designing Durability into Product Commercialization
Green Lunar: Turning Waste into Wealth with Dual-Function Halloysite Nanotubes for Lunar Agriculture and Medical Applications
Regulatory Validation and Commercialization of a Sprayable Hydrogel for Postoperative Adhesion Prevention
Scalability of Electrospun Polycaprolactone for Medical Devices: Overcoming Challenges for Commercialization